Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
European Journal of Drug Metabolism and Pharmacokinetics
|
August 23, 2019
Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine
Jan-Paul Bohn, Vera Reinstadler, Georg Pall, et al.
Cancers
|
November 27, 2024
Beta-2-Microglobulin Maintains Overall Survival Prediction in Binet A Stage Chronic Lymphocytic Leukemia Patients with Compromised Kidney Function in Both Treatment Eras of Chemoimmunotherapy and Targeted Agents
Jan-Paul Bohn, Valentina Stolzlechner, Georg Göbel, et al.
Clinical Kidney Journal
|
May 10, 2024
Rationale and design of the Innsbruck Diabetic Kidney Disease Cohort (IDKDC)-a prospective study investigating etiology and progression of early-stage chronic kidney disease in type 2 diabetes
Clemens Plattner, Sebastian Sallaberger, Jan-Paul Bohn, et al.
Frontiers in Immunology
|
August 6, 2024
Enhancement of complement-dependent cytotoxicity by linking factor-H derived short consensus repeats 19-20 to CD20 antibodies
Lena Prantl, Philipp Heider, Lisa Bergmeister, et al.
Genes, Chromosomes & Cancer
|
December 5, 2020
Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia-variant
Maurus Locher, Emina Jukic, Jan-Paul Bohn, et al.
American Journal of Hematology
|
May 19, 2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study
Patrizia Mondello, Caterina Musolino, Irene Dogliotti, et al.
Blood Advances
|
May 27, 2026
DUSP1 is a Key Driver of Disease Persistence and Potential Therapeutic Target in Hairy Cell Leukemia
Jan-Paul Bohn, Alexandra Scheiber, Gregor Sturm, et al.
Cancers
|
April 26, 2025
Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q
Magdalena Benda, Patrick Reimann, Elena Bletzacher, et al.
Blood
|
September 4, 2025
Acalabrutinib treatment for older (≥80 years old) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial
Florian Simon, Rudy Ligtvoet, Jan-Paul Bohn, et al.
The New England Journal of Medicine
|
December 8, 2025
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
Othman Al-Sawaf, Janina Stumpf, Can Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
European Journal of Drug Metabolism and Pharmacokinetics
|
August 23, 2019
Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine
Jan-Paul Bohn, Vera Reinstadler, Georg Pall, et al.
Cancers
|
November 27, 2024
Beta-2-Microglobulin Maintains Overall Survival Prediction in Binet A Stage Chronic Lymphocytic Leukemia Patients with Compromised Kidney Function in Both Treatment Eras of Chemoimmunotherapy and Targeted Agents
Jan-Paul Bohn, Valentina Stolzlechner, Georg Göbel, et al.
Clinical Kidney Journal
|
May 10, 2024
Rationale and design of the Innsbruck Diabetic Kidney Disease Cohort (IDKDC)-a prospective study investigating etiology and progression of early-stage chronic kidney disease in type 2 diabetes
Clemens Plattner, Sebastian Sallaberger, Jan-Paul Bohn, et al.
Frontiers in Immunology
|
August 6, 2024
Enhancement of complement-dependent cytotoxicity by linking factor-H derived short consensus repeats 19-20 to CD20 antibodies
Lena Prantl, Philipp Heider, Lisa Bergmeister, et al.
Genes, Chromosomes & Cancer
|
December 5, 2020
Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia-variant
Maurus Locher, Emina Jukic, Jan-Paul Bohn, et al.
American Journal of Hematology
|
May 19, 2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study
Patrizia Mondello, Caterina Musolino, Irene Dogliotti, et al.
Blood Advances
|
May 27, 2026
DUSP1 is a Key Driver of Disease Persistence and Potential Therapeutic Target in Hairy Cell Leukemia
Jan-Paul Bohn, Alexandra Scheiber, Gregor Sturm, et al.
Cancers
|
April 26, 2025
Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q
Magdalena Benda, Patrick Reimann, Elena Bletzacher, et al.
Blood
|
September 4, 2025
Acalabrutinib treatment for older (≥80 years old) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial
Florian Simon, Rudy Ligtvoet, Jan-Paul Bohn, et al.
The New England Journal of Medicine
|
December 8, 2025
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
Othman Al-Sawaf, Janina Stumpf, Can Zhang, et al.
Page
of 2